Apolipoprotein E ε4 and incidence of Alzheimer disease in a community population of older persons

JAMA

Volumn 277, Issue 10, 1997, Pages 822-824

  Evans, Denis A ^a,e   Beckett, Laurel A ^a   Field, Terry S ^d   Feng, Lin ^b,c   Albert, Marilyn S ^d   Bennett, David A ^a   Tycko, Benjamin ^b,c   Mayeux, Richard ^b,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c Harvard Medical School ^*  (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; DNA;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; ALLELE; COHORT ANALYSIS; GENE FREQUENCY; GENETICS; MULTIVARIATE ANALYSIS; STATISTICAL MODEL;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 0030614816     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.10.822     Document Type: Article

References (23)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
3. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
4. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993; 342:697-699.
5. Brousseau T, Legrain S, Berr C, Gourlet V, Vidal O, Amouyel P. Confirmation of the epsilon 48 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology. 1994; 44:342-344.
6. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein ∈4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994; 7:74-78.
7. Breitner JC, Welsh KA, Gau BA, et al. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans, III: detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol. 1995;52:763-771.
8. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA. 1989;62:2551-2556.
9. Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995;73:1354-1359.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services' Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
11. Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhAI. J Lipid Res. 1991;31:545-548.
12. Shah BV, Barnwell BG, Beiler GS. SUDAAN Users Manual: Software for Analysis of Correlated Data, Release 6.40. Research Triangle Park, NC: Research Triangle Park Institute; 1995.
13. Myers RH, Schaefer E, Wilson PWF, et al. Apolipoprotein E ∈4 association with dementia in a population study: the Framingham Study. Neurology. 1996;46;673-677.
14. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ. 1994;309:636-638.
15. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet. 1995; 346:1387-1390.
16. Blacker D, Haines JL, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology. 1997;48:139-147.
17. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and arteriosclerosis. Arteriosclerosis. 1988;8:1-21.
18. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 1991;49:338-349.
19. Kamboh MI. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Hum Biol. 1995;67:195-215.
20. Ordovas JM, Litwack-Klein L, Wilson PWF, Schaefer MM, Schaefer E. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoEl apoE5 isoforms. J Lipid Res. 1987;28:371-380.
21. Cauley JA, Eichner JE, Kamboh MI, Ferrell RE, Kuller LH. Apo E allele frequencies in younger (age 42-50) vs older (age 66-90) women. Genet Epidemiol. 1993;10:27-34.
22. Sorbi S, Nacmias B, Forleo P, et al. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett. 1994;177:100-102.
23. Corbo BM, Scacchi R, Mureddu L, Mulas G, Alfano G. Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrylamide gel isoelectric focusing technique: comparison with frequency data of other European populations. Ann Hum Genet. 1995;59:197-209.